Requiring Bureau for Public Health to test for mucopolysaccharidosis type 1

This bill requires West Virginia hospitals to add newborn screening for mucopolysaccharidosis type 1 (MPS1), a rare metabolic disorder that can be managed with early treatment but is not curable. It amends existing law to include MPS1 in the state's mandatory newborn screening program, which already tests for over 30 other conditions like sickle cell anemia and cystic fibrosis. The legislation ensures all infants born in West Virginia are tested for MPS1 shortly after birth, allowing for prompt medical intervention. This change directly affects newborns in West Virginia and aligns the state's screening protocol with current medical guidelines for MPS1.